Seguimento farmacoterapêutico domiciliar: a importância do farmacêutico na Estratégia de Saúde da Família

Abstract

The main point of entry to the Brazilian Unified Health System (SUS) is through Primary Health Care (PHC). As the Brazilian population ages, the Chronic Non-Communicable Diseases (CNCD) become the highest priority of health care. Considering the impacts of the CNCD, it is essential to adopt approaches that allow implementing proper therapeutic interventions to increase the effectiveness of the pharmacological treatment, which requires the strengthening of the SUS regarding the assistance of such patients, through the care models for chronic conditions and the expansion and qualification of the Family Health Strategy (FHS), prioritizing caring activities and autonomy of subjects. Thus, the present work identified and analyzed Negative Results Associated with Medication (NRM) in a group of 12 patients with diabetes mellitus and/or systemic arterial hypertension, aged over 65 years, in a FHS. The study was performed using the methodology proposed by the Dáder program of pharmacotherapeutic follow-up, which was developed by the research group in pharmaceutical care of the University of Granada, Spain. The method used included the steps: service offer, first interview, situational analysis, study phase, evaluation phase, and pharmaceutical intervention. The evaluation phase was created with the Delphi technique, which is a method of consensus of experts developed by Dalkey and Helmer. The panel of experts found 271 NRM, considering 22.1% by necessity (100% untreated health problem), 50.5% by effectiveness (70.1% non-quantitative ineffectiveness and 29.9% quantitative ineffectiveness), and 27.4% by security (52.7% quantitative insecurity and 47.3% non quantitative insecurity). Considering that the existence of NRM turn into major public health problems, the pharmaceutical care is an effective alternative in the search for better clinical and economic results, promoting health and preventing aggravations.